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RESEARCH
Diagnostic stability in children 
and adolescents with bipolar disorder, 
a nationwide register-based study
Mathilde Frahm Laursen1,2,7* , Rasmus W. Licht1,2, Christoph U. Correll3,4,5,6, Tobias Kallehauge1, 
Ann‑Eva Christensen1, Maria Rodrigo‑Domingo1 and René Ernst Nielsen1,2
Abstract 
Background: Diagnostic stability of bipolar disorder (BD) in children and adolescents, beyond the first contact has 
been investigated sparsely. The aim of this study was to investigate the diagnostic stability of BD in children and ado‑
lescents using over two decades of nationwide register‑based data, and to examine factors associated with change 
from BD to schizophrenia (ICD‑10: F20.x), schizoaffective disorder (ICD‑10: F25.x) or other primary psychotic disorders 
(ICD‑10 F23.x–24.x and F28.x–29.x).
Methods: Danish register‑based data for all incident BD patients diagnosed prior to age 18 years, between January 
1st 1995 and December 31st 2014 (N = 519). We graphically illustrated diagnostic change at different follow‑up times 
and studied variables associated with diagnostic change after 3‑year follow‑up using Poisson regression with robust 
standard error estimates.
Results: The diagnosis of incident BD was relatively stable. The diagnosis did not change for 93% of those followed 
for at least 6 months, and remained unchanged for 86% and 73% of those followed at least 3 years and 10 years, 
respectively. In patients followed for at least 3 years after index BD (N = 478), the risk of diagnostic change was 61% 
higher in males versus females. The risk of diagnostic change for patients diagnosed during hospitalization was 74% 
higher compared to patients diagnosed at outpatient clinics/emergency rooms. The risk of diagnostic change for 
patients abusing substances other than alcohol and cannabis was 173% higher compared to patients not abusing 
such substances. The risk of diagnostic change for patients previously diagnosed with schizophrenia or related diag‑
nosis was 257% higher compared to patients not having been diagnosed with such diagnosis previously, while the 
risk of diagnostic change in offspring of parents with schizophrenia or related diagnosis was 126% higher compared 
to patients who did not have parents diagnosed with such disorders.
Conclusion: Overall, the stability of the BD diagnosis in the Danish nationwide healthcare registers was high. Fac‑
tors associated with risk of diagnostic change within 3 years of the initial diagnosis were being male, diagnosis given 
during hospitalization, substance abuse other than alcohol and cannabis, and a prior diagnosis of schizophrenia or 
related diagnosis in the patient or in their parents.
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Background
When following patients with bipolar disorder (BD) lon-
gitudinally, a diagnostic change might indicate either a 
progression of illness course or a prior lack of diagnos-
tic precision. For example, it has been shown that pri-
mary psychotic disorders, i.e., psychotic non-affective 
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disorders, like schizophrenia (SCZ), can have an illness 
trajectory that develops over a substantial period of time 
(Salvatore et al. 2012; Bromet et al. 2011).
In the study by Fenning et  al. diagnostic stability was 
defined as the degree to which the original diagnosis is 
confirmed at follow-up (1994), and in some studies the 
diagnostic stability has been ascertained by measur-
ing the positive predictive value of the onset-diagnosis 
compared to the follow-up-diagnosis (Amin et al. 1999). 
Several studies have estimated the diagnostic stability 
of adult-onset BD (Fennig et  al. 1994; Amin et  al. 1999; 
Marneros et al. 1991; Chen et al. 1998). A register-based 
study of adults diagnosed with BD during the first psy-
chiatric contact [median age at first contact = 49.0 years 
(quartiles: 25.1–62.8)] with up to 9 years follow-up, 
showed that 31.2% had changed diagnosis during follow-
up at the 10th contact, with the majority (12.9%) chang-
ing to SCZ, schizotypal disorder, and delusional disorders 
(Kessing 2005). The authors further showed that the sta-
bility of the incident BD diagnosis among adults ranged 
from 85.4% at second contact to 68.8% at the 10th con-
tact, however, information on time related to the contacts 
was not provided.
In children and adolescents with bipolar disorder, 
called early-onset BD (EOBD), the diagnostic validity of 
EOBD has been called into question (Blader and Carl-
son 2007; Moreno et al. 2007). Despite this debate about 
EOBD, the stability of single manic episode and BD diag-
noses has only been investigated sparsely in youth. Gel-
ler et al. (2000) found in 2000 that 85.7% of their cohort 
of children and adolescents diagnosed with BD as per 
DSM-IV (American Psychiatric Association 2000) (mean 
age at baseline was = 10.9 ± 2.7 years) continued to have 
that diagnosis at the 6-months follow-up, however, the 
authors did not conduct long-time follow-up. In a reg-
ister-based study from 2014 by Kessing et al. (2015) the 
authors showed that 144 children and adolescents aged 
up to 19  years [median age at first contact = 17.4  years 
(quartiles: 16.3–18.2)] who were diagnosed with BD at 
first contact had a diagnostic stability of 76–83% from 
first to fifth contact, mean follow-up of 1.31 years (quar-
tiles: 0.65–2.48 years). However, in addition to the scar-
city of data about the diagnostic stability of BD in patients 
below age 18 years, detailed and longitudinal information 
about the change from BD to SCZ, schizoaffective disor-
der and other primary psychotic disorders are currently 
missing in this age group.
Thus, the aim of this study was to investigate the 
degree of diagnostic change in register-defined BD and 




This was a Danish nationwide register-based cohort 
study of BD included in the period January 1st, 1995 to 
December 31st, 2014 followed until April 28th, 2017. 
Potential factors for a diagnostic change within 3 years of 
index BD diagnosis were investigated. The contact lead-
ing to the first ever BD diagnosis is in the text referred to 
as the index.
Sample
The cohort consisted of children and adolescents with a 
first ever diagnosis of a single hypomanic episode, a sin-
gle manic episode or BD (ICD-10: F30.x–F31.x) (World 
Health Organization 1992) during the age of 5–17 years 
who were registered in the Danish National Patient Reg-
ister (NPR) (Lynge et al. 2011).
Registers utilized
The Civil Registration System uses a ten digit unique per-
son identification number (CPR-number) assigned to all 
Danish citizens upon birth or immigration that allows 
linking data from different registries (Pedersen 2011). 
The Civil Registration System contains information on 
family relationships, and whether the person had emi-
grated, was missing, or had died at the end of the study 
period. The Danish Psychiatric Central Research Register 
(DPCRR) (Mors et al. 2011) contains information on all 
psychiatric contacts in Denmark from 1969 and onward. 
The Danish National Patient Register (NPR) (Lynge et al. 
2011) contains information from 1977 and onward con-
cerning every contact with any type of hospital in Den-
mark, including psychiatric hospitals from 1995.
Measures
Outcomes
The main outcome was diagnostic change from BD to any 
of the following ICD-10 diagnoses: schizophrenia (F20.x), 
schizoaffective disorder (F25.x) and other primary psy-
chotic disorders (F23.x–24.x and F28.x–29.x) investi-
gated at six different time-points.
The secondary outcome was potential risk factors asso-
ciated with diagnostic change from BD to schizophrenia 
(ICD-10: F20.x), schizoaffective disorder (ICD-10: F25.x), 
or other primary psychotic disorders (ICD-10: F23.x–
24.x and F28.x–29.x) for patients followed at least 3 
years after index. Patients who received a different diag-
nosis (i.e. ICD-10: F20.x, 23.x–25.x and 28–29.x) during 
follow-up are referred to as the group with diagnostic 
change, while those who did not are referred to as the 
group with unchanged BD.
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Procedure
We identified all patients receiving a first ever BD diag-
nosis and computed their follow-up time after index. 
We investigated the proportion of remaining patients 
with a stable BD diagnosis as well as those changing to 
SCZ, schizoaffective disorder (SA), and other primary 
psychotic disorders (psychosis not otherwise specified, 
PNOS) at 6 months, 1 year, 2 years, 3 years, 5 years, and 
10  years from index. When relevant, we also present 
the percentage of patients changing between diagnos-
tic groups (e.g. from PNOS to SCZ). The study sample 
diminished over time due to administrative censoring.
We described the entire sample at baseline, and inves-
tigated potential factors for diagnostic change 3 years 
after index among the demographic and clinical factors 
described in the section below. Utilizing anonymized 
healthcare register-data prohibited us from publishing 
data in which single patients could be identified, there-
fore variables or frequency strata containing information 
on less than four patients and aggregated data based on 
less than five patients are not shown.
We did not specifically investigate if patients had 
another diagnostic change back to BD again, after an ini-
tial diagnostic change from BD to SCZ, SA and PNOS, 
nor did we investigate if they had been given other co-
morbid psychiatric diagnoses in the study period after 
the initial diagnostic change, as this was not within the 
scope of the study.
Demographic and clinical factors
Sex
Sex was defined according to the CPR register (Pedersen 
2011).
Psychiatric family history
History of psychiatric disorders in the parents was 
retrieved from the NPR and the DPCRR (Mors et  al. 
2011) and categorized into: (1) schizophrenia or related 
diagnoses (ICD-8: 295, 297, 298 excl. 298.0 and 298.1, 299 
(World Health Organization 1967) and ICD-10: F20.x–
F29.x (World Health Organization 1992), (2) Affective 
disorders (ICD-8: 296, 298.0, 298.1, 300.4 (World Health 
Organization 1967) and ICD-10: F30.x–F39.x (World 
Health Organization 1992), (3) Substance abuse [ICD-8: 
291, 294.3, 303, 304 (World Health Organization 1967) 
and ICD-10: F.10.x–F19.x (World Health Organiza-
tion 1992)], (4) Other psychiatric disorders (ICD-8: 291 
to 315 (excluding the above mentioned) (World Health 
Organization 1967) and ICD-10: Fxx.x (excluding the 
above mentioned) (World Health Organization 1992) and 
[ICD-8: E950–E959, E980–E989 (World Health Organi-
zation 1967) and ICD-10: X60–X84, Y10–Y34 (World 
Health Organization 1992)]. The parents were followed 
from start of register until 1 year after the EOBD diagno-
sis of the child.
Age at first bipolar‑spectrum diagnosis
Age at the index diagnosis was computed based on the 
date of birth and the date of first single hypomanic epi-
sode, single manic episode or first BD (ICD-10 F30.x/
F31.x) (World Health Organization 1992), retrieving the 
diagnosis from the NPR (Lynge et al. 2011). Age at first 
bipolar-spectrum diagnosis was further dichotomized 
into EOBD: < 13 vs ≥ 13 years of age.
Age at first psychiatric contact
Data on age at first psychiatric contact were retrieved 
from the DPCRR (Mors et al. 2011) and the NPR (Lynge 
et al. 2011).
Psychiatric contacts were defined as being registered 
with a primary diagnosis of any psychiatric disorder 
[ICD-8: 291–315 (World Health Organization 1967) 
and ICD-10: Fxx.x (World Health Organization 1992)], 
or intentional self-harm acts [ICD-8: E950–E959, E980–
E989 (World Health Organization 1967) and ICD-10: 
X60–X84, Y10–Y34 (World Health Organization 1992)].
Latest psychiatric diagnosis prior to BD diagnosis
Data on psychiatric contacts were retrieved from the 
NPR (Lynge et al. 2011) and the DPCRR (World Health 
Organization 1967) and categorized into: (1) schizo-
phrenia or related diagnoses (ICD-8: 295, 297, 298 excl. 
298.0 and 298.1, 299 (World Health Organization 1967) 
and ICD-10: F20.x–F29.x (World Health Organization 
1992), (2) Affective disorders [ICD-8: 296, 298.0, 298.1, 
300.4 (World Health Organization 1967) and ICD-10: 
F30.x–F39.x (World Health Organization 1992), (3) Sub-
stance abuse (ICD-8: 291, 294.3, 303, 304 (World Health 
Organization 1967)] and ICD-10: F.10.x–F19.x (World 
Health Organization 1992), (4) Other psychiatric disor-
ders (ICD-8: 291 to 315 (excluding the above mentioned) 
(World Health Organization 1967) and ICD-10: Fxx.x 
(excluding the above mentioned) (World Health Organi-
zation 1992) and [ICD-8: E950–E959, E980–E989 (World 
Health Organization 1967) and ICD-10: X60–X84, Y10–
Y34 (World Health Organization 1992)].
Substance abuse
Information on substance abuse was retrieved from the 
DPCRR (Mors et  al. 2011) and the NPR (Lynge et  al. 
2011) and coded into two separate dichotomous variables 
with the possible levels of yes and no. The first variable 
was substance abuse of any type before or at time of first 
manic episode or first BD diagnosis, including alcohol 
(ICD-8: 291 and 303 (World Health Organization 1967) 
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and ICD-10: F10.x) (World Health Organization 1992), 
cannabis (ICD-8 304.5 (World Health Organization 1967) 
and ICD-10: F12.x) (World Health Organization 1992), or 
substances other than alcohol or cannabis [ICD-8: 294.3, 
304 excl. 304.5 (World Health Organization 1967) and 
ICD-10: F11.x, F13.x–F19.x] (World Health Organization 
1992). The second variable was abuse of substances other 
than alcohol or cannabis (ICD-8: 294.3, 304 excl. 304.5 
(World Health Organization 1967) and ICD-10: F11.x, 
F13.x–F19.x) (World Health Organization 1992) before 
or at time of first manic episode or first BD diagnosis.
Diagnostic setting
Data on first ever BD diagnosis were retrieved from the 
NPR (Lynge et  al. 2011) and sub-divided into: (1) diag-
nosed during hospitalization or (2) diagnosed at outpa-
tient clinic or in the emergency room (ER).
Period of diagnosis
The year of diagnosis was retrieved from the NPR (Lynge 
et al. 2011) and classified into two periods: (1) First BD 
diagnosis between January 1st 1995 and December 31st 
2004, or (2) First ever BD diagnosis between January 
1st 2005 and December 31st 2014, since the number of 
patients newly diagnosed with BD has increased substan-
tially since 2005.
Psychotic BD diagnosis
When the first ever BD diagnosis was registered as psy-
chotic BD (ICD-10: F30.2, F31.2 and F31.5) (World 
Health Organization 1992), dichotomized into yes/no.
Statistical analysis
Demographic and clinical data were described using total 
numbers and percentages or means and standard devia-
tions, where appropriate.
The percentage of patients with a stable BD diagnosis 
and those changing to other diagnoses was illustrated 
graphically at different time-points. A sensitivity analysis 
was conducted excluding patients diagnosed with SCZ 
prior to first BD diagnosis.
Poisson regressions with robust standard errors were 
used to calculate the relative risk (Zou 2004) for diagnos-
tic change between the groups of sex, abuse of alcohol 
and cannabis or other substances, diagnostic setting, psy-
chotic BD diagnosis, year of diagnosis, latest psychiatric 
diagnosis prior to BD, psychiatric family history, respec-
tively, as well as for an increase of one in the continuous 
variables age at first ever BD diagnosis, and age at first 
psychiatric contact, respectively. Results with p < 0.05 
were considered statistically significant.
Statistical analyses were performed with Stata 15 
(StataCorp. 2017.  Stata Statistical Software: Release 15. 
College Station, TX: StataCorp LLC).
Results
Baseline demographic and clinical characteristics for all 
children and adolescents with a first ever BD diagnosis 
between 1995 and 2014 (N = 519) as well as for those fol-
lowed at least 3 years (N = 478) are present in Table 1. A 
lag of 1.5 years between the first psychiatric contact and 
first ever BD diagnosis was shown as well as only 7% of 
the sample being below age 13 years at time of first BD 
diagnosis (Table 1).
Diagnostic stability
Altogether, 519 patients received a first ever BD diagno-
sis during the study period. Within 6 months of the index 
diagnosis, 3% had changed diagnosis to SCZ, 1% to SA, 
and 3% to PNOS. The percentages that changed diagno-
sis at 1, 2, 3, and 5  years were similar, but were slightly 
higher for those followed at least 10 years (see Fig. 1).
Figure  1 shows transitions from BD to the specific 
diagnoses of SCZ, SA or PNOS after 6 months, 1, 2, 3, 5 
and 10 years. Results show that only a minor proportion 
changed from PNOS or SA to SCZ over time, and almost 
none changed diagnosis from PNOS to SA. Furthermore, 
diagnostic change from BD to SA or PNOS was relatively 
rare. Diagnostic change from BD to PNOS was at most 
6%, being 4% or less at all time-points for conversions 
from BD to SA. Most of the patients who changed diag-
nosis from BD did so to SCZ, and after 10 years of follow-
up, 17% of the available sample (n = 169) had changed 
diagnosis to SCZ. Still, the majority (73%) of the patients 
with initial BD diagnoses did not change diagnosis even 
10 years after the index BD diagnosis.
Our sensitivity analyses showed that excluding patients 
diagnosed with SCZ prior to the first ever BD diagnosis 
did not change percentages presented in Fig. 1 substan-
tially (data not shown).
Altogether, 478 patients (92.1% of the original sam-
ple) were followed for at least 3 years. Of those patients, 
86% continued to have an BD diagnosis whereas 14% had 
changed diagnosis to SCZ, SA or PNOS (Fig.  1). Forty-
one patients were followed for less than < 3  years and 
had a mean ± SD follow-up time of 2.39 ± 0.74 years. Of 
those, 11 children and adolescents changed diagnosis 
from BD to SCZ, SA or PNOS.
Factors associated with diagnostic change
Table  2 presents the number and percentages for the 
examined factors in the group with an unchanged BD 
diagnosis and in the group with a diagnostic change at 3 
years follow-up, as well as the RR of a diagnostic change.
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In patients followed for at least 3 years after index 
BD (N = 478), males had a RR = 1.61 (95% CI (1.03; 
2.53), p = 0.038) for a diagnostic change compared to 
females. Patients diagnosed during hospitalization had 
a RR = 1.74 (95% CI 1.11; 2.73), p = 0.015) for a diag-
nostic change compared to patients diagnosed at out-
patient clinics/ER. Patients abusing substances other 
than alcohol and cannabis had a RR = 2.73 (95% CI 
(1.48; 5.02) p = 0.001) for a diagnostic change compared 
to patients not abusing such substances. Patients pre-
viously diagnosed with SCZ or related disorder had a 
RR = 3.57 (95% CI (2.33; 5.47), p  < 0.001) for a changing 
diagnosis, compared to patients who had not been diag-
nosed with SCZ previously. Patients whose parents had 
previously been diagnosed with a SCZ or a related diag-
nosis had a RR = 2.26 (95% CI (1.32; 3.90) p = 0.003) for 
a diagnostic change compared to patients without par-
ents with SCZ or a related diagnosis (Table 2).
Discussion
Our investigation of the long-term diagnostic stability of 
BD according to the Danish registers showed that among 
patients with follow-up information 93% of the diagno-
ses were stable after 6 months, 90% after 1 year, 86% after 
2 and 3 years, 83% after 5 years, and 73% after 10 years, 
respectively.
The stability of BD in the Danish registers was inves-
tigated previously by Kessing et  al. (2015), who in the 
period from 1994 to 2012 in a cohort of 354 children and 
adolescents (age 0–19 years) found that, at their second 
psychiatric contact, 79.6% out of 98 patients continued 
to have a BD diagnosis and at fifth contact 77.3% out of 
22 patients with follow-up information still had the BD 
diagnosis. The results by Kessing et  al. (2015) resem-
ble the findings in the current study although the time 
intervals between visits are not reported by Kessing et al. 
(2015) and we only know that the total follow-up time 
Table 1 Characteristics of bipolar disorder (BD) in children and adolescents between 1995 and 2014
a Numbers could not be reported in order to comply with the data protection rules set by Statistics Denmark in order to avoid allowing identification of individual 
patients in cells containing ≤ 5 patients
Variables Total population included Total population 
with 3-year follow-up
N % N %
Children and adolescents with BD 519 100 478 92
Sex (females) 299 58 274 57
Family history of psychiatric disorders 162 32 –a –a
Family history of bipolar disorder 57 11 –a –a
Substance abuse total 53 10 48 10
Substance abuse, other than alcohol and cannabis 25 5 23 5
Diagnostic setting
 Inpatient 201 39 188 39
 Outpatient 318 61 290 61
Psychotic BD at index 92 18 90 19
Index BD prior to 2005 131 25 130 27
Index BD < 13 years 36 7 32 7
Latest psychiatric diagnosis prior to BD
 Schizophrenia or related diagnosis 93 18 86 18
 Affective disorders 130 25 117 24
 Substance abuse 40 8 37 8
 Other psychiatric disorders 286 55 263 55
Information about parents
 Schizophrenia or related diagnosis 44 9 –a –a
 Affective disorders 111 22 –a –a
 Substance abuse 77 15 –a –a
 Other psychiatric disorders 9 2 –a –a
Variables Mean SD Mean SD
Age at first ever BD 15.9 2.1 15.9 2.1
Age at first psychiatric contact 14.4 3.6 14.3 3.6
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was longer than 2.5  years for only 25% of the sample. 
Therefore, a direct comparison between the results from 
our study with the results of the second, third and fourth 
visits in the study by Kessing et al. (2015) were not possi-
ble, although both studies present supporting evidence of 
high diagnostic stability of the BD diagnosis in the Dan-
ish registers.
Furthermore, Kessing et al. found that 3.1% at the sec-
ond contact, increasing to 4.6% at the fifth contact, had 
changed diagnostically to SCZ or a related diagnosis 
(ICD-10 F20.x–29.x). However, that study did not inves-
tigate the proportions who changed from BD to SCZ 
specifically. Therefore, the findings in the current study 
demonstrating that 3% had changed diagnosis to SCZ 
after 6 months and 17% after 10 years cannot be directly 
compared to findings by Kessing et al. (2015).
The risk of diagnostic change was significantly higher 
for (1) males than females, (2) in-patients compared to 
outpatients and patients diagnosed in the ER, (3) patients 
who were using substances other than alcohol and can-
nabis, (4) patients diagnosed with a SCZ or related diag-
nosis before index BD, and (5) patients with parents who 
had been previously diagnosed with a SCZ or related 
diagnosis. Diagnostic change might have been a conse-
quence of illness progression with patients fulfilling the 
diagnostic criteria for ICD-10 BD at time of first ever 
BD diagnosis, and with a further progression in the psy-
chopathology later on, leading to the diagnostic shift to 
PNOS, SA or SCZ seen at later contacts. The findings 
could also be a results of patients being misdiagnosed 
with BD in the first place due to an overlap of symp-
toms (Murray et  al. 2004). However, notably, psychotic 
BD was not a significant factor for a diagnostic shift to 
SCZ or a related disorder. Nevertheless, affective dis-
turbances have been shown to be a part of the SCZ pro-
drome (Cornblatt et al. 2003) and, as such, symptoms of a 
SCZ prodrome could potentially be misdiagnosed as BD. 
Why males had a higher risk for changing diagnosis than 
females at the 3 year follow-up is unclear, but could be 
ascribed to the fact that males develop SCZ at an earlier 
age than females (Usall et al. 2002). Indeed, males might 
have fulfilled diagnostic criteria for BD at baseline, but 
due to illness progression, a substantial proportion would 
have fulfilled diagnostic criteria for a SCZ or related diag-
nosis 3 years after first BD diagnosis.
Fig. 1 Percentages of patients who changed diagnosis and patients continuing to have the diagnosis latest given to them. Percentages are 
computed using the number of patients available in the sample at each time point (N = 519 at baseline, N = 478 at 3 years follow‑up, N = 169 at 10 
years follow‑up). The sum of the percentages in the ovals for each time point is 100%, as is the sum of the arrow percentages (both horizontal and 
rightwards), except for rounding errors. Arrows representing less than four patients are depicted as green arrows without percentages if originating 
from Psychosis (PNOS) or Schizoaffective (SA) groups, or not represented at all if originating from Bipolar (BD) group
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Table 2 Bipolar disorder (BD) in children and adolescents with and without diagnostic change after 3 years of follow-up 
(N = 478)
Group with unchanged BD 
(N = 412)
Group with diagnostic 
change (N = 66)
RR (95% CI) p value
N (%) N (%)
Sex 0.038
 Female 244 (89.1%) 30 (10.9%)
 Male 168 (82.4%) 36 (17.6%) 1.61 (1.03; 2.53)
Family history of psychiatric disorder 0.310
 No –a (87%) –a (13%)
 Yes –a (84%) –a (16%) 1.27 (0.80; 2.03)
Family history of BD 0.629
 No –a (86%) –a (14%)
 Yes –a (88%) –a (12%) 0.82 (0.37; 1.18)
Substance abuse (total) 0.286
 No 373 (86.7%) 57 (13.3%)
 Yes 39 (81.3%) 9 (18.8%) 1.41 (0.75; 2.68)
Substance abuse of other than alcohol and 
cannabis
0.001
 No 397 (87.3%) 58 (12.7%)
 Yes 15 (65.2%) 8 (34.8%) 2.73 (1.48; 5.02)
Diagnostic setting 0.015
 Outpatient or ER 259 (89.3%) 31 (10.7%)
 Inpatient 153 (81.4%) 35 (18.6%) 1.74 (1.11; 2.73)
Psychotic BD at index 0.055
 No 340 (87.6%) 48 (12.4%)
 Yes 72 (80.0%) 18 (20.0%) 1.62 (0.99; 2.64)
Index BD prior to 2005 0.988
 No 300 (86.2%) 48 (13.8%)
 Yes 112 (86.2%) 18 (13.8%) 1.00 (0.61; 1.66)
Index BD < 13 years
 No 384 (86.1%) 62 (13.9%)
 Yes > 27 (–%)1 < 5 (–%)1 –a –a
Latest psychiatric diagnosis prior to BD
 Schizophrenia or related diagnosis < 0.0001
  No 355 (90.6%) 37 (9.4%)
  Yes 57 (66.3%) 29 (33.7%) 3.57 (2.33; 5.47)
 Affective disorders 0.568
  No 313 (86.7%) 48 (13.3%)
  Yes 99 (84.6%) 18 (15.4%) 1.16 (0.70; 1.91)
 Substance abuse 0.655
  No 381 (86.4%) 60 (13.6%)
  Yes 31 (83.8%) 6 (16.2%) 1.19 (0.55; 2.57)
 Other psychiatric disorders 0.134
  No 191 (88.8%) 24 (11.2%)
  Yes 221 (84.0%) 42 (16.0%) 1.43 (0.90; 2.29)
Information about parents (N = 473)
 Schizophrenia or related diagnosis 0.003
  No –a (88%) –a (12%)
  Yes –a (72%) –a (28%) 2.26 (1.32; 3.90)
 Affective disorders 0.680
  No –a (87%) –a (13%)
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Lastly, BD can be more difficult to diagnose in children 
and adolescents than in adults, as reflected in two similar 
studies using different age groups by Kessing et al. (2005, 
2015) who found that only 40.7% of children and adoles-
cents got a diagnosis of mania or BD at first in- or outpa-
tient contact in contrast to 56.2% of adults. In the current 
study the vast majority of the sample was diagnosed 
with an incident BD registry diagnosis between 13 and 
18 years of age, making the study mostly comparable to 
other studies investigating BD in adolescents. However, 
future studies should focus of identifying symptoms that 
overlap, characteristics with the highest specificity for a 
diagnostically stable BD, or a diagnostically stable SCZ 
disorder diagnosis, and predictors of diagnostic change 
from BD to SCZ.
Strengths and limitations
The results of this study need to be interpreted in light of 
several limitations. First, we investigated only false posi-
tives, but not false negatives, i.e., to what degree patients 
are misdiagnosed and there is a substantial delay between 
the actual illness onset and the diagnosis of BD in chil-
dren and adolescents. Second, we only investigated if 
patients with BD had diagnostic change to a SCZ, SA or 
PNOS, but we did not investigate all diagnoses given sub-
sequently. It is possible to receive another BD diagnosis 
after a SCZ, SA or PNOS diagnosis, but we considered 
this as unlikely and therefore we did not investigate this 
issue. In a study by Laursen et al. (2019), using the Danish 
registers, it was found that only 2.3% of children and ado-
lescents below age 18 years changed diagnosis from SCZ 
to BD during the study period (1995–2014). Third, we did 
not investigate comorbidities. After receiving a BD diag-
nosis, patients might later on be referred to psychiatric 
care primarily due to an ICD-10 F4.x diagnosis, e.g. anxi-
ety (Faedda et al. 2014; Duffy et al. 2016), however, such 
conditions are frequently comorbid with BD, for which 
reason, BD would still be present. Fourth, we included 
single hypomanic episode and single manic episode as 
part of BD since we believed that a single hypomanic 
episode or a single manic episode will most likely be fol-
lowed by another mood episode (Kessing 2005; Good-
win 2002). Fifth, there is a possibility of underreporting 
of the true incidence of BD because a proportion of BD 
might be misdiagnosed with e.g. major depression (Lish 
et al. 1994; Hirschfeld et al. 2003). Furthermore, the reg-
istry reflects clinical practice and is influenced by refer-
ral to hospital-based psychiatry as well as diagnostic 
culture. Sixth, we were unable to ascertain the true sen-
sitivity as well as specificity of the BD diagnosis in the 
register because there is no information about the false 
and true negatives. Finally, results may not fully general-
ize to other countries, regions and health care systems, 
which is why similar studies are needed in other areas of 
the world. In the current study only few changed diag-
nostic group to PNOS and SA, thus, it was not possible 
to analyze whether factors associated with increased risk 
of diagnostic change would differ in those groups, com-
pared to what was shown in Table 2. Lastly, in the current 
dataset we do not have SES data available and as such we 
were unable to investigate the effects thereof on diagnos-
tic change.
Despite these limitations, this study has also several 
strengths. First, we used population-based nationwide 
registers and, since public healthcare in Denmark is 
free of charge, we included all patients diagnosed with 
BD without exclusion based on socioeconomic status or 
geographical location, as is the case in some insurance 
a The exact numbers could not be reported in order to comply with the data protection rules set by Statistics Denmark in order to avoid allowing identification of 
individual patients in cells containing ≤ 5 patients
Table 2 (continued)
Group with unchanged BD 
(N = 412)
Group with diagnostic 
change (N = 66)
RR (95% CI) p value
N (%) N (%)
  Yes –a (85%) –a (15%) 1.12 (0.66; 1.91)
 Substance abuse 0.928
  No –a (86%) –a (14%)
  Yes –a (86%) –a (14%) 1.03 (0.55; 1.92)
 Other psychiatric disorders 0.438
  No –a (86%) –a (14%)
  Yes –a (> 55%) –a (< 45%) 1.64 (0.47; 5.68)
Mean (SD) Mean (SD) RR (95% CI) p-value
Age at first ever BD diagnosis (N = 478) 15.9 (2.1) 16.0 (2.1) 1.01 (0.91; 1.13) 0.857
Age at first psychiatric contact (N = 478) 14.4 (3.5) 14.0 (4.3) 0.98 (0.92; 1.04) 0.465
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database healthcare studies. Second, the study had mini-
mal loss to follow-up owing to the mandatory reporting 
of all data on in-patients and out-patients to the Danish 
health care registers. Third, we have been able to follow 
the majority of patients for at least 3 years after index and 
a quite large proportion for up to 10 years, which to our 
knowledge is the longest follow-up period investigating 
the diagnostic stability of BD.
Conclusion
The diagnosis of the BD in the Danish registers is rela-
tively stable. The risk for diagnostic change from BD to 
SCZ, SA, or PNOS 3 years after first ever BD diagnosis 
are higher for males, inpatients, patients who had a SCZ 
or related diagnosis prior to first ever BD diagnosis, 
patients using substances other than alcohol and canna-
bis, and for patients whose parents had received a SCZ or 
related diagnosis. These risk factors should be considered 
and used in the screening and diagnostic practice as well 
as when following patients with BD longitudinally.
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